{"id":19867,"date":"2026-02-13T18:41:24","date_gmt":"2026-02-13T17:41:24","guid":{"rendered":"https:\/\/www.cbd.fr\/blog\/?p=19867"},"modified":"2026-02-13T18:41:25","modified_gmt":"2026-02-13T17:41:25","slug":"medical-cannabis-passed-in-the-national-assembly-using-article-49-3","status":"publish","type":"post","link":"https:\/\/www.cbd.fr\/blog\/medical-cannabis-passed-in-the-national-assembly-using-article-49-3\/","title":{"rendered":"Medical cannabis passed in the National Assembly using Article 49.3"},"content":{"rendered":"

As part of the 2024 social security financing bill, the National Assembly adopted the legalization of medical cannabis in France. Prime Minister \u00c9lisabeth Borne’s use of Article 49.3 of the Constitution allowed this controversial measure to be adopted without a vote by the members of parliament.<\/p>\n

<\/h2>\n

The Stakes of Medical Cannabis in France After several years of legalization in other countries, medical cannabis has finally arrived in France.<\/strong><\/p>\n

Several conditions can be treated with this new treatment, including spasticity associated with multiple sclerosis, refractory nausea and vomiting associated with chemotherapy, and severe epilepsy resistant to other treatments.<\/p>\n

<\/h2>\n

However, many doctors, scientists, and experts continue to debate the benefits and risks associated with the use of medical cannabis. Proponents emphasize the potential benefits for many people suffering from chronic illnesses, while opponents warn of possible side effects and the dangers of self-medication. <\/strong>The Controversial Use of Article 49.3<\/p>\n

The Prime Minister’s use of Article 49.3 of the Constitution has sparked strong criticism from the opposition, which denounces an<\/p>\n

\n
\n

Sommaire<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n